Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8969 - 8976 of 12089 results

EB-5 Due Diligence Matters: Industry at Point of Inflection Regarding Securities Compliance
November 3, 2015| Blog| Viewpoint

Federal Court Allows Terminated Employee to Proceed with Age Discrimination Claim Despite Her Execution of a Release of Claims
November 3, 2015| Blog| Viewpoint

NLRB Discusses Joint Employment for the First Time Since Browning-Ferris
November 3, 2015| Blog| Viewpoint

Immigration and Nationality Act 50th Anniversary Series: National Origin Quotas to Skills & Family Based Immigration
November 3, 2015| Blog| Viewpoint

CBP Announces the Expansion of Global Entry to UK Citizens
November 3, 2015| Blog| Viewpoint

Severance Payments May be Recoverable in a Company's Bankruptcy
November 2, 2015| Blog| Viewpoint

New York Wage Deduction Amendments Renewed for Another Three Years
November 2, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
